Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

BACKGROUND: Effective diuretic regimens using loop diuretics in patients with acute decompensated heart failure are often limited by the development of worsening kidney function....

BACKGROUND: Effective diuretic regimens using loop diuretics in patients with acute decompensated heart failure are often limited by the development of worsening kidney function....

BACKGROUND: REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethylā€”Intervention Trial) reported a 25% relative risk reduction in major adverse cardiovascular events with use of...

  • 1542377611686424578 Profile photo of Madelyn

    1/2 An important paper was just published on biomarker study in REDUCE-IT (EPA vs mineral oil). It shows the mineral oil "placebo" group had significant increases in 7 biomarkers associated with higherCVD risk, incl Lp(a) (2.4%) and IL1-b (48%). https://t.co/9Ds3Dnnfm2 - view on twitter

A 57-year-old woman presented with 2 months of typical angina, cough, and syncope. She had a history of anomalous RCA arising from the pulmonary...

BACKGROUND: In the CABANA trial (Catheter Ablation vs Antiarrhythmic Drug Therapy for Atrial Fibrillation), catheter ablation did not significantly reduce the primary end point...

BACKGROUND: Immune checkpoint inhibitors (ICIs) are monoclonal antibodies used to activate the immune system against tumor cells. Despite therapeutic benefits, ICIs have the potential...

In 2010, the American Heart Association defined a novel construct of cardiovascular health to promote a paradigm shift from a focus solely on disease...

In 2010, the American Heart Association defined a novel construct of cardiovascular health to promote a paradigm shift from a focus solely on disease...

BACKGROUND: REDUCE-IT (Reduction of Cardiovascular Events With Icosapent Ethylā€”Intervention Trial) reported a 25% relative risk reduction in major adverse cardiovascular events with use of...

  • 1542074516381237248 Profile photo of Madelyn

    Secondary analysis of REDUCE-IT trial of icosapent ethyl shows mineral oil placebo worsened many biomarkers: šŸ“ˆ 16.2% for interleukin-6 šŸ“ˆ 18.5% for lp-PLA2 šŸ“ˆ 21.9% for hs-CRP šŸ“ˆ 28.9% for interleukin-1Ī² https://t.co/Q8TOaix619 - view on twitter

Background: The role of diabetes in the development of valvular heart disease and particularly the relation with risk factor control, has not been extensively...

  • 1541749208910336000 Profile photo of Madelyn

    In this large registries study from Sweden, individuals with type 1 & 2 #diabetes had a greater risk of stenotic valve lesions, whereas the risk for valvular regurgitation was lower in those with type 2 diabetes. ā¦@CircAHAā© #wondrmedical https://t.co/uGGJdbpMiL - view on twitter